Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (NY:ATNM)

1.670 -0.140 (-7.73%)
Streaming Delayed Price Updated: 12:29 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 238,660
Open 1.730
Bid (Size) 1.670 (3)
Ask (Size) 1.680 (4)
Prev. Close 1.810
Today's Range 1.600 - 1.797
52wk Range 1.029 - 10.24
Shares Outstanding 21,331,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Securities Fraud Investigation Into Actinium Pharmaceuticals, Inc. (ATNM) Announced – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Actinium Pharmaceuticals, Inc. (ATNM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire

Performance

YTD
+32.5%
+32.5%
1 Month
+45.2%
+45.2%
3 Month
+42.7%
+42.7%
6 Month
-11.2%
-11.2%
1 Year
-80.5%
-80.5%

More News

Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATNM
From Pomerantz LLP
Via GlobeNewswire
Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Securities Fraud Investigation Into Actinium Pharmaceuticals, Inc. (ATNM) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Actinium Pharmaceuticals, Inc. (NYSE American: ATNM)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Top movers in Wednesday's pre-market session
Via Chartmill
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements
Via FinancialNewsMedia
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week
Via Stocktwits
Which stocks are gapping on Thursday?
Via Chartmill
Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-A’s Backbone Therapy Strategy
Via FinancialNewsMedia
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ATNM Investors Have Opportunity to Join Actinium Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024
Via InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Tumbles 950 Points; ISM Services PMI Surges In July
Via Benzinga
Topics Stocks
Exposures US Equities
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
Via Benzinga
Exposures Product Safety
Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
Via Benzinga
3 Under-$10 Biotech Stocks That Could Make You Rich
Via InvestorPlace

Frequently Asked Questions

Is Actinium Pharmaceuticals, Inc. (Delaware) Common Stock publicly traded?
Yes, Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is publicly traded.
What exchange does Actinium Pharmaceuticals, Inc. (Delaware) Common Stock trade on?
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock?
The ticker symbol for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is ATNM on the New York Stock Exchange
What is the current price of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock?
The current price of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is 1.670
When was Actinium Pharmaceuticals, Inc. (Delaware) Common Stock last traded?
The last trade of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock was at 03/31/25 12:29 PM ET
What is the market capitalization of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock?
The market capitalization of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is 35.62M
How many shares of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock are outstanding?
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock has 36M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.